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Circulatory inflammatory proteins play a significant role in anti-Candida host immune
defence. However, little is known about the genetic variation that contributes to the
variability of inflammatory responses in response to C. albicans. To systematically
characterize inflammatory responses in Candida infection, we profiled 91 circulatory
inflammatory proteins in peripheral blood mononuclear cells (PBMCs) stimulated with
C. albicans yeast isolated from 378 individuals of European origin from the 500 Functional
Genomics (500FG) cohort of the Human Functional Genomics Project (HFGP) and
Lifelines Deep cohort. To identify the genetic factors that determine variation in
inflammatory protein responses, we correlated genome-wide single nucleotide
polymorphism (SNP) genotypes with protein abundance (protein quantitative trait loci,
pQTLs) produced by the Candida-stimulated PBMCs. Furthermore, we investigated
whether differences in survival of candidaemia patients can be explained by modulating
levels of inflammatory proteins. We identified five genome-wide significant pQTLs that
modulate IL-8, MCP-2, MMP-1, and CCL3 in response to C. albicans. In addition, our
genetic analysis suggested thatGADD45G from rs10114707 locus that reached genome-
wide significance could be a potential core gene that regulates a cytokine network upon
Candida infection. Last but not least, we observed that a trans-pQTL marked from SNP
rs7651677 at chromosome 3 that influences urokinase plasminogen activator (uPA) is
strongly associated with patient survival (Psurvival = 3.52 x 10
-5, OR 3). Overall, our genetic
analysis showed that genetic variation determines the abundance of circulatory proteins in
response to Candida infection.
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INTRODUCTION
Candida species are by far the most common fungal pathogens
that cause both invasive and mucosal fungal infections. They
have been described as the fourth most common cause of
nosocomial bloodstream infection in the United States (1, 2).
Invasive candidiasis causes more than 250,000 new systemic
infections on a yearly basis and leads to more than 50,000 deaths
(3). Most humans are colonized with C. albicans shortly after
birth, which remains as part of a normal human’s microbiota.
Infection occurs only if the epithelial barrier function is impaired
and/or there are microbiome imbalances and/or the host
immune system is compromised. Under these conditions,
Candida can invade tissue and reach blood circulation. The
bloodstream carries Candida to almost all vital organs, leading
to systemic infections and, eventually, to organ failure followed
by death.
Protective immunity to Candida involves both innate and
adaptive cellular and humoral responses (4, 5). Cytokines and
chemokines are a group of low molecular weight proteins that
contribute significantly to anti-Candida host immune defence by
acting as mediators between immune and non-immune cells, by
enhancing the antifungal activity of immune cells and by attracting
inflammatory immune cells to the site of infection. Earlier studies
have shown the capacity of C. albicans to induce production of
various cytokines and chemokines (6–9). However, all previous
studies focused on a narrow spectrum of inflammatory proteins,
and a systematic study of inflammatory proteins released in the
blood circulation upon C. albicans infection is lacking. Given that
proteins are inherently influenced by genetic factors, it is important
to assess the impact of host genetics on Candida-induced
inflammatory proteins. By studying the genetics of only six
different cytokines upon Candida-stimulation, we showed that
host genetics play a major role in inter-individual variability in
cytokine responses, and single nucleotide polymorphisms (SNPs)
affecting cytokine responses are associated with susceptibility to
candidaemia (9–11). Given that disease prognosis of candidaemia
patients is generally poor, and survival rates differ greatly among
them (12), we also assumed that genetic variation determines
patient survival. Therefore, we hypothesized that modulation of
circulatory inflammatory proteins may determine the differences in
survival among patients.
The aims of the present study were to identify the abundance
of differentially regulated inflammatory proteins in peripheral
blood mononuclear cells (PBMCs) stimulated with C. albicans
yeast, and to investigate whether genetic variants influence
inflammatory proteins (pQTLs) in the context of Candida
infection (Figure 1). For this, we profiled 91 inflammatory
proteins in the PBMCs isolated from two independent
population-based cohorts, the 500 Functional Genomics
(500FG) cohort of the Human Functional Genomics Project
(HFGP, http://www.humanfunction-algenomics.org), and
Lifelines Deep cohort (https://www.lifelines.nl/). We observed
that the majority of inflammatory proteins were significantly
increased in Candida-stimulated PBMCs compared to control
PBMCs stimulated with RPMI 1640 medium. In addition,
association of genetic variation with protein abundance
identified 5 independent novel, genome-wide significant
protein quantitative trait loci (pQTLs, P < 5 x 10-8). Lastly, we
investigated whether pQTLs determine patient survival in
candidaemia, and identified a locus on chromosome 3 that
may determine survival through modulating urokinase




To understand the variation in circulating inflammatory proteins
in humans in response to C. albicans in vitro, we used two
independent population-based cohorts, the 500FG, and the
Lifelines Deep cohorts.
500FG
The 500FG cohort is composed of healthy individuals of Western
European ancestry from the Human Functional Genomics
Project (HFGP, see www.humanfunctionalgenomics.org). The
500FG cohort is composed of 533 well-characterized healthy
individuals, 237 males and 296 females, all between 18 and
75 years old.
Demographic Data Collection in 500FG. Volunteers, after
donating blood in the hospital, received an extensive online
questionnaire about lifestyle, diet, and disease history. Based on
the results of this questionnaire, 45 volunteers were excluded for
various reasons, e.g., they were under medication, non-European
ancestry, or had a chronic disease. These exclusion criteria were
taken to minimize false positive effects on the protein production
capacity in vitro.
Lifelines Deep Cohort
Participants of the northern Netherlands population cohort
LifeLines Deep (13) are part of the Lifelines cohort in the
Netherlands (www.lifelines.nl/researcher/cohort-and-biobank).
This unique Lifelines cohort is consisted of 1539 participants
aged 18 years and older, of which multiple data levels are
available for follow-up research.
Candidaemia Cohort. Enrollment of candidaemia patients
occurred between January 2003 and January 2009. The
demographic and clinical characteristics of the candidaemia
cohort have been described previously (14). For this study, a
subgroup of patients consisted of 171 individuals, which were
recruited at the Duke University Hospital (DUMC), were
followed prospectively for up to 3 years and survival outcome
was recorded for these individuals. Of these individuals, 115 were
identified as non-survivors and 56 as survivors. These
candidaemia patients had European ancestry and must have
had at least one positive blood culture for a Candida species, with
the majority of them infected by C. albicans.
Abbreviations: SNP, single-nucleotide polymorphism; PBMCs, peripheral blood
mononuclear cells; GWAS, Genome-wide association study; pQTL, protein
quantitative trait locus.
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Genotyping, Quality Control, and Imputation of the
Study Populations
500FG Cohort
Genotyping, quality control (QC) and imputation of the 500FG
cohort were previously described (9). Briefly, DNA obtained and
was genotyped using the commercially available Illumina
HumanOmniExpressExome-8 v1.0 SNP chip. Upon QC per
sample and SNP, genotypes were imputed using the Genome
of the Netherlands (GoNL) as a reference panel (15). Before QTL
mapping, we performed standard quality control per sample and
SNP using the imputed genotypes of 482 samples. Upon QC per
sample (Supplementary Figure 1), four samples were removed
as duplicated samples and 18 samples due to high relatedness
(PI_HAT > 0.2). As a measure of relatedness, we used the
estimates of PI_HAT (proportion identity-by-decent) as
calculated using plink v1.90b (16). One additional sample was
removed due to reduced heterozygosity rate (3 standard
deviations below the mean of heterozygosity rate). Excess
heterozygosity rate may indicate sample contamination and
reduced heterozygosity may indicate inbreeding. Lastly, 11
samples were removed as ethnic outliers based on the
multidimensional scaling analysis (performed in PLINK on the
N X N matrix of genome-wide IBS pairwise distance) (MDS)
using the first two principal components (PC1 and PC2)
(Supplementary Figures 2A, B). Ethnic outliers are defined as
the samples which showed a value of PC1 and/or PC2 three
standard deviations above or below the mean of PC1 and PC2. In
total, we identified 30 genetic outliers of which 12 had protein
FIGURE 1 | Overview of our study. We profiled the proteins released from C. albicans-stimulated PBMCs isolated from healthy individuals belonging to the 500FG
(n = 364) and Lifelines Deep cohort (n = 63). We first compared the expression of proteins from Candida-stimulated samples (n = 337) with RPMI 1640-stimulated
samples (n = 24) from the 500FG cohort to identify proteins that were significantly differentially expressed between the two conditions. Before DE protein analysis, we
removed outliers that failed QC from OLINK proteomics (n = 26 samples) and one additional sample which had no age and sex information, resulting in 337 samples
for DE analysis. In addition, we studied the effect of host genetics on the regulation of inflammatory responses by performing a meta-analysis of pQTLs mapped in
the 500FG and Lifelines Deep cohorts. For pQTL mapping, we used the proteomic data measured in the 500FG (n = 364) and Lifelines Deep cohort (n = 63). We
also obtained the imputed genotypes of the studied individuals. After removing outliers based on the quality control of the genotypes and proteomic data, the total
number of samples used for pQTL mapping was 326 and 52 samples in the 500FG and Lifelines Deep cohort respectively. After quality control, we correlated the
protein measurements with genome-wide SNP data in each cohort and performed meta-analysis using the summary statistics of pQTLs mapped in the two cohorts
to identify genetic variants that influence the levels of inflammatory proteins. Stimulations of PBMCs were performed for 24 hours using C. albicans yeast and RPMI
1640 medium as control.
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measurements. Finally, we removed genetic variants with MAF <
5%, resulting in a total number of 5,464,689 variants that were
used for follow-up pQTL mapping.
Lifelines Deep Cohort
Genotyping, quality contol and genotype imputation of the
Lifelines Deep cohort have been published elsewhere (17).
Briefly, DNA was isolated and genotyped using both the
HumanCytoSNP-12 BeadChip and the ImmunoChip platforms
(Illumina, San Diego, CA, USA). First, SNP quality control was
applied independently for both platforms, and next the
genotypes generated from both platforms were merged into
one dataset. After merging and quality control, genotypes were
imputed using the GoNL reference panel (15). For this study, we
used 63 Candida-stimulated PBMC samples from which we
measured proteins from the supernatant using OLINK
proteomics as described below. Before QTL mapping, we
performed QC per sample and SNP using the imputed
genotypes as described for the 500FG cohort (Supplementary
Figure 1). In total, we removed 11 outliers due to high
relatedness, resulting in a total number of 52 samples for
follow-up QTL mapping. Finally, we removed genetic variants
with MAF < 5%, resulting in a total number of 5,464,689 variants
that were used for pQTL mapping.
Candidaemia Cohort
Genotyping, QC and imputation of the candidaemia cohort were
previously described (11). Isolated DNA obtained from
candidaemia patients was genotyped using the commercially
available SNP chips, HumanCoreExome-12 v1.0 and
HumanCoreExome-24 v1.0 BeadChip from Illumina (https://
www.illumina.com). Genotypes were imputed using the
Michigan imputation server with the human reference
consortium (HRC) as a reference panel to increase the number
of SNPs to ~5 millions (18). After imputation, we performed
standard QC per sample and SNP using our survival cohort
consisted of 171 candidaemia patients. The survival cohort
consisted of 115 non-survivors and 56 survivors. After
excluding genetic variants with a MAF < 0.01, we applied QC
per sample and removed 3 non-survivors due to high relatedness
(PI_HAT ~ 0.99). We also removed 3 non-survivors and 1
survivor due to excess/reduced heterozygosity that show a
value of heterozygosity rate 3 standard deviations above or
below the mean of heterozygosity rate respectively. In addition,
we identified 5 non-survivors and 3 survivors as ethnic outliers
based on MDS of candidaemia cases using the first two principal
components (Supplementary Figures 3A, B). After QC per SNP
and sample, we tested for association with survival of ~5 million
SNPs with MAF > 0.01 using 104 non-survivors and 52 survivors
as described below.
PBMC Collection and Candida
Stimulation Experiments
Venous blood from the cubital vein of healthy volunteers was
drawn in 10 ml EDTA Monoject tubes (Medtronic, Dublin) after
obtaining written informed consent. PBMC isolation was
performed as previously described (9). In short, the PBMC
fraction was obtained using density centrifugation of EDTA
blood diluted 1:1 in pyrogen-free saline over Ficoll-Paque
(Pharmacia Biotech, Uppsala). Cells were then washed twice in
saline and suspended in RPMI 1640 medium supplemented with
gentamycin (10 mg/mL), L-glutamine (10 mM) and pyruvate
(10 mM). PBMCs were counted in a Coulter counter (Beckman
Coulter, Pasadena) and re-suspended in a concentration of 5 x
106 cells/mL. A total of 5 x 105 PBMCs were added in 100 mL to
round-bottom 96-well plates (Greiner) and incubated with 100
mL of stimulus (heat-killed Candida albicans yeast of strain
ATCC MYA-3573, UC 820, 1 x 106/mL) or RPMI 1640
medium. After 24 hours, the supernatants were collected and
stored at −20°C until assayed using the proximity extension assay
(PEA) that is being used from Olink Proteomics (https://www.
olink.com/).
Fungal Growth Conditions
C. albicans ATCC MYA-3573 (UC 820) was grown overnight to
generate yeast cells in Sabouraud dextrose broth at 29°C, with
shaking. Cells were harvested by centrifugation, washed twice
with PBS, and resuspended in culture medium (RPMI 1640
Dutch modification). C. albicans yeast was heat killed for 30 min
at 95°C.
RNA Sequencing and Differential
Expression Analysis Using the
GoNL Cohort
All bulk RNA-seq data from PBMCs was previously generated
(10) in 70 individuals from the GoNL cohort (15) This data was
generated from PBMCs that were stimulated for 24 h with
Candida or remained unstimulated (RPMI 1640 control
condition). Principal components analysis (PCA) of the gene
expression data generated from the Candida- and RPMI 1640-
stimulated PBMCs showed that two samples were possibly
mislabelled, which were subsequently removed before
differential expression (DE) analysis (Supplementary Figure 4).
The differentially expressed genes upon stimulation were
identified through DESeq2 package from Bioconductor using
72 Candida-stimulated- and 75 RPMI 1640-stimulated samples
(19). The statistically significant threshold (FDR < 0.05)
was applied.
Proteomic Profiling of Circulating
Inflammatory Proteins
Supernatant samples of PBMCs stimulated with C. albicans yeast
and with RPMI 1640 control medium were analyzed using the
proximity extension assay (PEA) that is being used from Olink
Proteomics (20). We selected the Olink® inflammatory panel
(Olink Bioscience AB, Uppsala, Sweden). This panel includes 92
inflammatory proteins. To note, due to technical issues identified
in the brain-derived neurotrophic factor (BDNF) assay from the
Olink proteomics, we were unable to report any data for this
analyte, and thus, we reported in this study only 91 inflammatory
proteins (Table S1). Olink proteomics delivers the protein
measurements as Normalized Protein Expression (NPX)
values, which are Cq values normalized by the subtraction of
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values for extension control, as well as inter-plate control. The
scale is shifted using a correction factor (normal background
noise) and reported in the Log2 scale. We performed normality
test on both raw and log-transformed data using Shapiro-Wilk
normality test, and a P > 0.05 was used as a threshold for normal
distribution. The majority of proteins followed a non-Gaussian
distribution. The distribution of all protein measurements
generated from Candida-stimulated PBMCs from 500FG and
Lifelines Deep cohort are shown in Supplementary Figures
5A, B respectively. In addition to QC for protein distribution,
Olink Proteomics performed QC per sample during which
samples that deviate less than 0.3 NPX from the median pass
the quality control.
Clustering Analysis
To assess the correlation structure between pairs of inflammatory
proteins measured in at least 85% of samples from Candida-
stimulated PBMCs isolated from the 500FG cohort, unsupervised
clustering was performed using Spearman’s correlation as the
measure of similarity. All statistical analyses were performed in R
version 3.2.2.
Differential Expression Protein Analysis
To test which proteins are differentially expressed in Candida-
stimulated PBMC samples (n = 364) versus RPMI 1640-
stimulated PBMC samples (n = 24) in the 500FG cohort, we
performed a DE analysis using a linear model with age and sex as
covariates. Twenty-six out of 364 Candida-stimulated PBMC
samples did not pass QC per sample performed by OLINK
proteomics as described above (Figure 1). All samples stimulated
with RPMI 1640 control medium passed quality control. After
removing outliers, 337 Candida-stimulated samples (one sample
out of the 338 samples was removed due to missing phenotype
information) and 24 RPMI 1640-stimulated samples used for DE
analysis. The total number of proteins that were measured in at
least 85% of all samples and tested for DE analysis was 36
proteins. For DE analysis, we used the R package Limma adjusted
to protein data, which is originally being used for the analysis of
gene expression data (21). Limma uses an empirical Bayes
method to moderate the standard errors of the estimated log-
fold changes. Proteins with an FDR < 0.05 and a logarithm of fold
change (logFC) > 2 compared to RPMI 1640-stimulated samples
were considered statistically significant. Normalized protein
measurements (NPX values) for all samples used in the DE
analysis are provided in Table S2.
Protein QTL Mapping
We performed a meta-analysis of Candida-induced pQTLs by
using the summary statistics of the pQTL datasets that were
mapped in the two independent population-based cohorts, the
500FG and Lifelines Deep cohort. Lack of protein measurements
for all available individuals restricted us to select 364 individuals
from 500FG and 63 samples from Lifelines Deep cohort for
whom both genotype and protein data were available (Figure 1
and Supplementary Figure 1). In addition to the outliers that
did not pass the QC from Olink Proteomics, we removed genetic
outliers before QTL mapping as described above. In total, we
removed 14 genetic outliers from the 500FG cohort and 11
genetic outliers from the Lifelines Deep cohort, resulting in 326
samples from 500FG cohort and 52 samples from the Lifelines
Deep cohort (Supplementary Figure 1). To correct the protein
distributions for QTL mapping, we used a linear model adjusting
for age and sex. NPX values of protein levels were used, and the
correlation between protein abundance and genotype was tested
independently for the two cohorts using the R-package Matrix-
eQTL (22).
Next, we performed meta-analysis using the summary
statistics of pQTLs that influence proteins that were measured
in at least 85% of the samples in both cohorts. HGF protein was
one of the proteins that was not measured sufficiently in the
500FG cohort in contrast to the Lifelines Deep cohort (Table S1),
and, hence, the number of proteins that used for meta-analysis
was 35 proteins. To jointly test the effect of genetic variation in
protein levels measured in both 500FG and Lifelines cohort, we
used METAL (http://www.sph.umich.edu/csg/abecasis/metal/)
using 35 proteins from 326 samples of the 500FG cohort and
52 samples of the Lifelines Deep cohort. Finally, we removed
pQTLs from meta-analysis with opposite direction and those
that show significant heterogeneity (P < 0.05) between the two
cohorts (23). We considered P < 5 x 10-8 to be the threshold for
genome-wide significant pQTLs.
Genotype-Dependent Gene Expression
Analysis at rs10114707 Locus
Both genotype and gene expression data upon Candida
stimulation were available from 62 individuals of the GoNL
cohort (15). The stimulation experiments and the RNA
sequencing analysis of this dataset has been previously
described (10). There were 32, 22 and 8 individuals carrying
AA, GA and GG genotypes respectively at rs10114707 locus. We
combined GA and GG in one group and performed DE analysis
between two genotype groups (GA+GG versus AA) using the
expression data of cis-genes (n = 30) extracted from the 5 GWAS
loci (in a window of 1MB around each GWAS locus), which were
identified in the meta-analysis of protein-QTLs. For DE analysis
using gene counts, we used the DESeq2 package (19). Summary
statistics of the DE analysis is shown in Table S3.
Pleiotropy
To test all reported genome-wide significant pQTLs for
pleiotropy, we initially inspected all genome-wide significant
trans-pQTLs whether they show association with multiple
distinct proteins. To correct for the multiple testing burden for
all genome-wide pQTLs, we next inspected all genome-wide
significant trans-pQTLs that had at least two associations with
distinct proteins at P < 0.05/(5*35) = 0.0003. This cut-off
represents a conservative approach to the multiple testing
burden for all identified, independent GWAS SNPs (n = 5)
with all protein traits (n = 35). The resulting association matrix
was then visualized as a heatmap based on the negative log2 of
the P values of association.
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Within Case/Control Association Analysis
for Candidaemia Survival
To identify genetic variants that are associated with survival, we
ran a within-case genome-wide association study using our
survival cohort consisted of 171 candidaemia patients, of
which 115 were identified as non-survivors and 56 as
survivors. After quality control per SNP and sample, we tested
for association with survival of ~5 million SNPs using 104 non-
survivors and 52 survivors. Age and sex were included as
covariates in an additive model using a frequentist association
test from SNPTEST v.2.5.4-beta3 (24). The quantile-quantile
(QQ) plot that shows the distribution of the observed negative
log10 P values for the whole-genome SNPs against the theoretical
distribution of expected negative log10 P values indicated no or
little evidence of population stratification (Supplementary
Figure 6). The genomic inflation factor based on median was
equal to l = 1.03.
RESULTS
Overview of Inflammatory Protein Profiles
in PBMCs From Healthy Individuals in
Response to C. albicans
To systematically study the inflammatory responses in the
context of C. albicans infection, we first obtained PBMCs from
364 individuals of European origin from the 500FG cohort. We
next measured the abundance of 91 inflammatory proteins in the
supernatant of PBMCs in response to C. albicans yeast
stimulation (Figure 1). Of these proteins, 36 were detected in
at least 85% of the samples (Table S1), and all proteins showed
significant inter-individual differences to C. albicans stimulation
compared to RPMI 1640 medium stimulation (Supplementary
Figure 7). After removing samples that failed the QC (n = 24)
and a sample with no age and sex information, we compared the
abundance of the 36 proteins between stimulated (n = 337) and
un-stimulated (using RPMI 1640 medium as control, n = 24)
conditions by performing DE protein analysis using a linear
model with age and sex as covariates. We identified significant
up-regulation of 25 proteins out of 36 measured in at least 85% of
PBMC samples that showed logFC > 2 compared to RPMI 1640-
stimulated samples (adjusted P value < 0.05) (Supplementary
Figure 8A and Table S4). Next, we compared the correlation
structure among the inflammatory proteins released from
PBMCs by performing unsupervised clustering of the protein
responses. Clustering revealed that the majority of proteins
showed a strong positive correlation (P < 0.01) (Supplementary
Figure 8B, Table S5), with the exception of IL-8 and MCP-1,
indicating the coordinated inflammatory protein response upon
Candida stimulation.
Identifying Genetic Variation Affecting
Inflammatory Proteins in Response
to C. albicans
Next, we investigated whether host genetic variation affects the
inter-individual differences in inflammatory responses to C.
albicans stimulation. For this, we used the genome-wide SNP
genotype data and protein measurements of Candida-stimulated
PBMCs isolated from two independent population-based cohorts
consisting of 364 individuals from 500FG cohort and 63
individuals from Lifelines Deep cohort. Upon quality control
(see Materials and Methods), we obtained 326 samples from
500FG cohort and 52 samples from the Lifelines Deep cohort with
a total of 35 inflammatory proteins that were measured in at least
85% of the samples in both cohorts. For pQTL mapping, we
selected SNPs that showed a minor allele frequency (MAF) >= 5%
and passed other quality filters (see Materials and Methods).
Using the protein and genotype data, we mapped pQTLs using
each cohort independently and performed meta-analysis using
the summary statistics of pQTLs identified in each cohort
(n = 378). Meta-analysis revealed five independent trans-pQTLs
that reached genome-wide significance level (P < 5 x 10-8, P for
heterogeneity > 0.05) (Table 1 and Figure 2). These include one
independent pQTL for IL-8 (chromosome 9), one for MCP-2
(chromosome 4), one for MMP-1 (chromosome 9) and two for
CCL3 (chromosome 9 and 15).
Prioritization of cis-Genes at pQTLs That
Affect Protein Abundance In Circulation in
Response to C. albicans
In these five independent loci, we prioritized potential causal
genes following two approaches. First, we tested whether genes
TABLE 1 | Genome-wide significant pQTL loci that were identified in the meta-analysis of pQTLs identified in the 500FG and Lifelines Deep cohort.
Chr SNP BP Allele1 Allele2 MAF Z
score
P-value Protein cis-gene(s)
4 rs59199268 16118500 A G 0.08 5.71 1.11x10-8 MCP-2 TAPT1a,b, CD38b, FAM200Bb, FGFBP2b, LDB2b, TAPT1-AS1b, FGFBP1b,
BST1b, FBXL5b
9 rs12343816 11477574 T C 0.18 5.81 6.37x10-9 CCL3 HRASLS2c, NRP1c, TMEM38Ac
9 rs10114707 92309687 G A 0.27 5.51 3.64x10-8 MMP-1 GADD45Gb, UNQ6494b, CKS2b, SECISBP2b, SEMA4Db
9 rs658817 1439567 T G 0.05 5.79 6.87x10-9 IL-8 RN5S279d, DMRT2d
15 rs55642284 69922759 A G 0.16 5.74 9.62x10-9 CCL3 GLCEb, LINC00593b, PAQR5b, KIF23b, TLE3b, RPLP1b, RP11-279F6.3d,
LOC145837d
aSNP or proxy SNP (LD > 0.8) shows an expression-QTL (eQTL) effect in blood (eQTLGen Consortium).
bGene is differentially expressed upon C. albicans stimulation at 24 hours.
cSNP or proxy SNP (LD > 0.8) shows an expression-QTL (eQTL) effect in peripheral blood monocytes.
dClosest annotated genes to pQTL.
MAF, Minor allele frequency calculated in the combined cohort of 500FG and Lifelines Deep cohort; Chr, chromosome; BP, Position in base-pairs; Allele1, Minor allele; Allele2, Major allele.
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that are located within 1MB window around the genome-wide
significant SNPs were differentially expressed in response to C.
abicans yeast stimulation after 24 hours in PBMCs using our
previously published Candida-induced transcriptomic dataset
generated from the Dutch population-based cohort, GoNL
(Table S6) (10). Secondly, we made use of the largest cis- and
trans-expression quantitative trait locus (eQTL) study in blood
from a total of 31,684 individuals through the eQTLGen
Consortium (25) to test if the genome-wide SNPs affect gene
expression in whole blood (Table 1) or in human monocytes
(26). Our strategy prioritized several interesting genes including
CD38 and GADD45G. Briefly, CD38 gene is prioritized from the
rs591999268 locus at chromosome 4 based on its significant
differential expression upon 24-hour Candida stimulation
(adjusted P 9.75 x 10-50, log2 of fold change = 3.25). This
finding suggests that CD38 may affect protein levels upon C.
albicans stimulation. CD38 is a glycoprotein widely expressed in
cells from the immune system, and animal studies indicate that it
confers protection against infection by several bacterial and
parasitic pathogens (27), suggesting its role on regulation of
inflammatory protein response. As a second example, growth
arrest and DNA damage inducible gamma (GADD45G) gene
from the rs10114707 locus at chromosome 9 was prioritized
based on two levels of evidence. Firstly, GADD45G is
significantly differentially expressed in response to C. albicans
at 24 hours (adjusted P 4.61 x 10-97, log2 of fold change = 2.63).
Secondly, we tested if GADD45G gene is differentially expressed
among individuals carrying different genotypes (AA, GA and
GG) at rs10114707, which could explain how SNP rs1011477 can
affect the levels of inflammatory proteins. For this, we stratified
individuals from the GoNL cohort based on their genotype at
rs10114707 locus and tested whether cis-genes in a window of
1MB around each GWAS locus is differentially expressed. We
observed that individuals heterozygous or homozygous for the
minor allele G at rs10114707 tend to show a decrease in
GADD45G expression compared to individuals homozygous
for allele A (Figure 3 and Table S3). Such stimulation specific
expression QTLs will be helpful to identify potential regulators of
inflammatory protein response.
Pleiotropy of Loci Affecting Protein Levels
It is possible that the same genetic locus may regulate multiple
proteins (pleiotropy). To test the presence of such pleiotropic
effects, we extracted all possible associations of genome-wide
significant pQTLs with the 35 proteins in the same allelic
direction between the two cohorts. We observed that all
FIGURE 2 | Genome-wide protein-QTL mapping identified five C. albicans yeast-induced pQTLs. Manhattan plot showing the genome-wide QTL mapping results
for C. albicans-induced MCP-2 (red), IL-8 (green), MMP-1 (blue), and CCL3 levels (purple). The y-axis represents the negative log10 P values of pQTLs. Their
chromosomal positions are shown on the x axis. The horizontal dashed line represents the genome-wide significance threshold for association (P < 5 x 10-8).
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genome-wide significant pQTLs influence multiple distinct
proteins (Figure 4A and Table S7), indicating the pleiotropic
effects of the pQTLs on the proteins. To account for multiple
testing, we inspected all genome-wide significant trans-pQTLs
that had at least two associations with distinct proteins at
P = 0.05/(5*35) = 0.0003. This cut-off represents a conservative
approach to correct for multiple testing for all identified GWAS
SNPs (n = 5) with all protein traits (n = 35). SNP rs59199268 at
chromosome 4 and rs55642284 at chromosome 15 showed only a
single association with MCP2 and CCL3, respectively. We
observed three loci on chromosome 9 at genetic variants
rs10114707, rs12343816 and rs658817 that influence four, two
and another two proteins respectively at P < 0.0003 in the same
allelic direction (Table S7). These pleiotropic effects suggest that
A B
FIGURE 3 | (A) Regional association plot at rs10114707 (purple diamond) that influences MMP-1, which is in close proximity to GADD45G gene at chromosome 9.
Each dot represents a SNP, which shows a meta-analysis P value < 0.05 and the same direction in the 500FG and Lifelines Deep cohort. The linkage disequilibrium
(LD) of neighboring SNPs with the top SNP is color-coded. The y-axis represents negative logarithm of P values of SNPs. The x-axis shows chromosomal positions
on Genome build GRCh37 (hg19). (B) Genotype-stratified gene expression levels of GADD45G at rs10114707 locus. Individuals carrying the minor allele G at this
locus showed a decrease in GADD45G expression. We presented the regularized-logarithm (rlog; transformed data on the log2 scale) of the counts of GADD45G
gene from the two-genotype groups (GA+GG versus AA).
A B C
D E
FIGURE 4 | Pleiotropy between genome-wide significant pQTLs and inflammatory proteins measured using the proximity extension assay (PEA) by Olink proteomics.
Heatmap (A) shows the negative log2(P) of all possible associations of the genome-wide significant pQTLs and the measured inflammatory proteins that show the same
allelic direction between 500FG and Lifelines Deep cohort at a P value of 0.0003, and Pheterogeneity ≥ 0.05. Boxplots showing the expression levels (as NPX values) of
(B) VEGFA, (C) TNF, (D) MMP-1, and (E) CCL20 when individuals from the 500FG and Lifelines Deep cohorts stratified by genotype at the genome-wide locus,
rs10114707.
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these proteins are co-regulated in inflammation induced by C.
albicans. For instance, individuals carrying the minor allele G at
rs10114707 seem to upregulate the levels of VEGFA, TNF,
MMP-1, and CCL20 (Figures 4B–E). We prioritized
GADD45G as a potential causal gene at this locus as discussed
above. GADD45 proteins are known to be induced by a number
of cytokines and by bacterial lipopolysaccharide, have an essential
role in the differentiation of myeloid cells as well as in the function
of granulocytes and macrophages (28, 29). Given this important
immune-regulatory function it is plausible that GADD45G could
be one of the core regulators of multiple inflammatory proteins.
However, more studies are needed to explain the specific
mechanism by which these pleiotropic effects occur.
Contribution of pQTLs That Influence
Circulatory Inflammatory Proteins to
Survival to Candidaemia
Next, we aimed to investigate whether genetic variation that
influences inflammatory proteins (pQTLs) in blood circulation
may determine patient survival to candidaemia. To identify
genetic variants that are associated with survival in candidaemia
patients, we performed a within-case GWAS analysis using 156
individuals, of which 104 were identified as non-survivors and 52
as survivors. After QC per SNP and sample, we tested 5450489
variants (MAF > 1%) for association with survival using an
additive model with age and gender as covariates. No genome-
wide significant associations were observed (P < 5 x 10-8), which
can be explained due to the small number of patients with
reported survival outcome (Figure 5). To test whether genetic
variants that are associated with survival influence inflammatory
proteins in response to Candida, we extracted the within-case
GWAS summary statistics of survival and overlaid this with our
trans-pQTLs at a P threshold 1 x 10-4. A trans-pQTL, rs7651677,
at chromosome 3 that influences uPA (P 8.29 x 10-6, z score 4.46),
also known as urokinase, showed a significant association with
survival (P 3.52 x 10-5 and OR 3), indicating that this locus may
determine survival of candidaemia patients through modulating
uPA. In this regard, it is interesting to note that the serum suPAR
(soluble urokinase plasminogen activator receptor) levels are
considered as a biomarker to assess the risk in sepsis (30).
DISCUSSION
The incidence of opportunistic invasive fungal infection has been
increased over the last decades. This increase can be explained by
FIGURE 5 | Manhattan plot showing the genome-wide P values of association with survival. The y axis represents the negative log10 P values and their
chromosomal positions are shown on the x axis. The locus marked at SNP rs7651677 on chromosome 3 that influences uPA (P 8.29 x 10-6, z score 4.46) and
shows a strong association with survival (P 3.52 x 10-5 and OR 3) is highlighted with green.
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the use of aggressive and intensive chemotherapeutic regimens,
immunosuppressive therapy for autoimmune disorders, and
transplantation that have led to a rise in the number of
susceptible human hosts (31). The development of specific and
mechanistically relevant plasma biomarkers in Candida
infections are therefore important tools in identifying patients
at high-risk and, thus, clinicians can provide the most beneficial
prophylactic and/or treatment strategy. In this study, we
performed a systematic proteomic analysis of plasma levels of
inflammatory-related proteins in PBMC samples in response to
Candida stimulation. To our knowledge, this is the first effort to
date to evaluate a great number of inflammatory proteins and
assess the role of host genetics in regulating inflammatory
protein levels in Candida infection.
We observed an increased inter-individual variation in
inflammatory responses in PBMCs stimulated with C. albicans
compared to RPMI 1640 medium-stimulated samples
(Supplementary Figure 7), suggesting that (non)-genetic
factors influence cytokine production capacity in humans.
Previous studies have shown that age, sex and seasonality are
important factors that influence immune responses (32). By
studying the most important pro-inflammatory cytokines
produced by monocytes, Th1 and Th17 cells (IL-6, TNF-a, IL-
1b, IL-17, IL-22 and IFN-g), we showed that host genetics play a
major role in inter-individual variability in cytokine responses
(9). In this study, to explain the observed inter-individual
variations in a broader spectrum of inflammatory responses, we
investigated the contribution of genetic factors to inflammatory
responses by performing a meta-analysis of pQTLs using two
independent population-based cohorts, the 500FG and Lifelines
Deep cohort. We identified 5 independent pQTLs with MAF
> 5% that reached genome-wide significance level (P < 5 x 10-8)
that influence IL-8, MCP-2, MMP-1, and CCL3. Similar to
previous findings (9), all pQTLs that we find are trans-QTLs,
and thus, influence inflammatory responses indirectly through
regulatory loops. These findings not only help to identify specific
genetic variants that affect cytokine levels but also provide
insights into trans-regulatory mechanisms. For example, we
found a SNP, rs10114707, near GADD54G gene that affects not
only MMP-1 levels but also four other inflammatory protiens
(VEGFA, TNF, IL-6 and CCL20, Table S7). GADD45G encodes a
protein that belongs to the family of Gadd45 proteins that are
important components of intracellular signaling networks that
are activated by a number of cytokines and lipopolysaccharide,
mediating intercellular communication in response to invading
pathogens (28). GADD45G has been reported to interact with
several proteins that are involved in DNA repair, cell cycle
control, apoptosis and senescence (33–35). Therefore, we
hypothesized that GADD45G could be a potential core gene
that regulates a cytokine network upon Candida infection.
Identifying such core genes that regulates cytokine networks
will be critical to better understand inflammatory processes
during infections.
Moreover, we investigated the contribution of trans-pQTLs
identified in the meta-analysis to patient survival. Despite the
small size of the patient cohort with known survival outcome, we
observed that a single locus marked from SNP rs7651677 at
chromosome 3 that influences uPA is strongly associated with
patient survival (Psurvival = 3.52 x 10
-5, OR 3). Interestingly, the
uPA has been previously reported to convert plasminogen to
plasmin, which then activates matrix metalloproteinases (MMPs),
such as MMP-9, degrading extracellular matrix structure.
Previous mouse studies demonstrated that certain species of
bacteria, such as Group A streptococcus, can recruit plasmin
accumulation on the cellular surface, consequently degrading the
extracellular matrix, and initiating bacterial invasion (36).
Previous studies also showed that C.albicans, among other
pathogenic bacteria, may use plasmin for its invasion by
binding plasminogen as well as expressing a range of proteins
that function as plasminogen receptors (37). Although inhibiting
plasminogen activation by uPA is considered as a therapeutic
target for invasive bacterial infection, more investigations are
needed to establish the role of uPA and plasminogen in
Candida infections.
There are also limitations to our study. First, the experimental
setup of ex vivo PBMC stimulation for 24 hours with C. albicans
yeast provides only the opportunity to study the interactions
between immune cells, such as monocytes, T and B cells, missing
the neutrophils and platelet fractions. Also, the use of heat-killed
C. albicans does not fully represent the interactions between live
Candida cells and PBMCs. Another limitation is that the time-
dependent dynamic interactions are missing as PBMCs were
stimulated for 24 hours. As such, other inflammatory responses,
which are triggered by the late-stage proteins of C. albicans
infections may be missed. In addition, it would be interesting to
capture inflammatory responses upon stimulation with C.
albicans hyphae, as the transition to hyphae contributes to C.
albicans virulence, as well as other C. albicans strains or Candida
species of different virulence, as some variability in terms of
immunological responses may occur depending on the strain or
species that is being used. In addition, although we validated the
pQTLs in an independent cohort, because of relatively small
sample size, we cannot exclude that some of the pQTLs were false
positives. Also, it would be interesting to extend this study to
populations other than Europeans as population-specific genetic
factors may drive differences in inflammatory responses in
response to Candida. In conclusion, we investigated in-depth
the inflammatory proteins in response to Candida infection, and
specifically the genetic variability that could modulate the
expression of these proteins. Our genetic analysis suggested
that GADD45G from rs10114707 locus that reached genome-
wide significance could be a potential core gene that regulates a
cytokine network upon Candida infection. We also investigated
whether pQTLs determine patient survival in candidaemia
patients and identified a single locus on chromosome 3 that
affects uPA that is strongly associated with patient survival. This
protein, which is known to interact with C. albicans may be a
potential therapeutic target to improve patient outcome. Overall,
this study provided an important groundwork to employ various
-omics data in response to Candida infection using large
population-based cohorts in the context of candidaemia where
currently available patient cohorts are of limited size. This study
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can trigger critical future work to understand better the
contribution of genetics to the inflammatory responses against
C. albicans and how they shape survival in candidaemia patients.
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Supplementary Figure 1 | Flowchart of the quality control (QC) per sample,
protein and SNP in the 500FG and Lifelines Deep cohort. The initial number of
Candida-stimulated samples from the 500FG with protein measurements was
364 samples. Olink Proteomics performed QC per sample during which samples
that deviate less than 0.3 NPX from the median pass the quality control. Twenty-
six samples were failed QC from OLINK proteomics in the 500FG cohort. In
addition, 12 samples were removed as genetic outliers. After removing outliers
based on the proteomic and genotype data, the final number of samples used for
pQTL mapping was 326 samples in the 500FG cohort. In the Lifelines Deep
cohort, the initial number of Candida-stimulated samples with protein
measurements was 63. All samples pass QC from OLINK proteomics, and 11
samples were removed as genetic outliers, resulting in a total number of 52
samples for pQTL mapping. Upon QC per protein, we used proteins that were
measured in at least 85% of samples, resulting in a total number of 36 and 47
proteins in the 500FG and Lifelines Deep cohort respectively. In both cohorts,
SNPs with MAF < 5% were removed before QTL mapping, resulting in
approximately 5 M SNPs in each cohort. Finally, we used the summary statistics
of pQTLs mapped in each cohort for meta-analysis. Proteins that were measured
in at least 85% of all samples in both cohorts were used for meta-analysis,
resulting in 35 proteins.
Supplementary Figure 2 | Multidimensional scaling (MDS) analysis was
performed on the 500FG cohort to identify ethnic outliers. (A) MDS plot before
removing ethnic outliers and (B) after removing ethnic outliers. As genetic outliers
were identified as those samples with PC1 and/or PC2 three standard deviations
above or below the mean of PC1 and/or PC2.
Supplementary Figure 3 | Multidimensional scaling (MDS) analysis was
performed on candidaemia patients grouped in non-survivors (n = 115
individuals, green dots) and survivors (n = 56 individuals, yellow dots). (A) MDS
plot highlighting the ethnic outliers. As ethnic outliers were identified as those
samples with PC1 and/or PC2 three standard deviations above or below the
mean of PC1 and/or PC2 (8 individuals, orange dots). (B) MDS plot after
removing the ethnic outliers.
Supplementary Figure 4 | Principal component analysis (PCA) for all genes
measured in PBMC samples stimulated with C. albicans (green dots) versus RPMI
1640 medium-stimulated samples (yellow dots) in the GoNL cohort.
Supplementary Figure 5 | Distribution plots of proteins measured in
supernatant of Candida-stimulated PBMC samples from the (A) 500FG cohort
and (B) Lifelines Deep cohort. The total number of proteins that were measured in
at least 85% of samples was 36 proteins and 47 in the 500FG and Lifelines Deep
cohort respectively. The total number of shared proteins between the two cohorts
that were measured in at least 85% of the samples and used for meta-analysis
was 35 proteins. Axis x represents the protein expression levels as NPX values (in
Log2 scale).
Supplementary Figure 6 | Quantile-Quantile (QQ) plot of association P-values for
all SNPs on the genome-wide genotyping array (Black dots). The genetic inflation
factor l for all SNPs was 1.03, indicating no population stratification in the survival
cohort of candidaemia patients.
Supplementary Figure 7 | Inflammatory proteins showed significant inter-
individual differences to C. albicans stimulation compared to RPMI 1640 medium
control in the 500FG cohort.
Supplementary Figure 8 | (A) Differential expression protein analysis in Candida-
stimulated versus RPMI 1640 medium-stimulated PBMC samples from the 500FG
cohort. Volcano plot of proteins showing significantly differentially expressed proteins
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with adjusted P < 0.05 (red). Benjamini-Hochberg method used to correct for multiple
testing, and adjusted P values < 0.05 were considered significant. Age and sex used
as covariates. (B) Unsupervised hierarchical clustering of inflammatory proteins that
were measured in at least 85% of PBMC samples stimulated with C. albicans yeast.
Spearman’s correlation was used as the measure of similarity. The blue color depicts
the strong positive correlation whereas the red color indicates the strong negative
correlation. Correlations between pairs of proteins that show a P value > 0.01 were
crossed on the plot.
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